Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: A report from the International Myeloma Working Group Immunotherapy Committee Review
| Authors: | Lin, Y.; Qiu, L.; Usmani, S.; Joo, C. W.; Costa, L.; Derman, B.; Du, J.; Einsele, H.; Fernandez de Larrea, C.; Hajek, R.; Ho, P. J.; Kastritis, E.; Martinez-Lopez, J.; Mateos, M. V.; Mikhael, J.; Moreau, P.; Nagarajan, C.; Nooka, A.; O'Dwyer, M.; Schjesvold, F.; Sidana, S.; van de Donk, N. W. C. J.; Weisel, K.; Zweegman, S.; Raje, N.; Rodriguez Otero, P.; Anderson, L. D. Jr; Kumar, S.; Martin, T.; on behalf of the International Myeloma Working Group |
| Review Title: | Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: A report from the International Myeloma Working Group Immunotherapy Committee |
| Journal Title: | Lancet Oncology |
| Volume: | 25 |
| Issue: | 8 |
| ISSN: | 1470-2045 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2024-08-01 |
| Start Page: | e374 |
| End Page: | e387 |
| Language: | English |
| DOI: | 10.1016/s1470-2045(24)00094-9 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PUBMED: | 38821074 |
| DOI/URL: | |
| Notes: | Erratum issued, see DOI: 10.1016/S1470-2045(24)00337-1 -- Source: CINAHL Plus with Full Text |
